Published in J Clin Pathol on December 01, 1974
Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut (1979) 1.12
Transthyretin in endocrine pancreatic tumors. Am J Pathol (1989) 0.78
Protein malnutrition alters spleen cell proliferation and IL-2 and IL-10 production by affecting the STAT-1 and STAT-3 balance. Inflammation (2014) 0.76
[A prealbumin of human serum]. Biochem Z (1956) 2.02
Pre-albumin: a thyroxinebinding protein of human plasma. Endocrinology (1958) 2.00
A multi-sample applicator for zone electrophoresis. Clin Chim Acta (1967) 1.67
METABOLISM OF IODINE-131--LABELED THYROXINE-BINDING PREALBUMIN IN MAN. Science (1965) 1.23
[Studies on pre-albumin in human serum. I. Methodical statements on paper electrophoretic demonstration of pre-albumin on filter paper; quantitative changes of pre-albumin]. Klin Wochenschr (1958) 0.88
Multivariate analysis of serum protein assays in chronic hepatitis and postnecrotic cirrhosis. Clin Chem (1974) 0.87
PHOSPHATASE IN OBSTRUCTIVE JAUNDICE. Can Med Assoc J (1934) 5.77
FAT EMBOLISM. Ann Surg (1939) 3.75
Group A streptococci resistant to lincomycin. Br Med J (1968) 2.32
Rupture of the Right Rectus Simulating Appendicitis. Can Med Assoc J (1924) 1.92
The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol (1998) 1.90
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity. Proc Natl Acad Sci U S A (2001) 1.81
Method for the detection and identification of alpha fetoprotein in serum. J Clin Pathol (1970) 1.80
Separation of haemoglobins on cellulose acetate. J Clin Pathol (1969) 1.80
THE CONTINUOUS INTRAVENOUS ADMINISTRATION OF PHYSIOLOGICAL SALT SOLUTION. Ann Surg (1930) 1.79
Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials (1991) 1.70
A multi-sample applicator for zone electrophoresis. Clin Chim Acta (1967) 1.67
Mortality, morbidity, resource allocation, and planning: a consideration of disease classification. Br Med J (1980) 1.59
A new approach (cyano-transfer) for cyanogen bromide activation of Sepharose at neutral pH, which yields activated resins, free of interfering nitrogen derivatives. Biochem Biophys Res Commun (1982) 1.52
Serum-alpha 1-fetoprotein in hepatocellular carcinoma. Lancet (1974) 1.51
Pitfalls of Australia antigen detection and screening. J Clin Pathol (1971) 1.50
Heliotherapy in Surgical Tuberculosis. Can Med Assoc J (1922) 1.49
Fractures of the Os Calcis : Their Treatment by Tri-Radiate Traction and Subastragalar Fusion. Ann Surg (1946) 1.45
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
A Simple Apparatus for the Continuous Intravenous Administration of Physiological Salt Solution. Can Med Assoc J (1928) 1.39
NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J Cell Biol (1997) 1.30
Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials. J Biomed Mater Res (1994) 1.26
An improved chromogenic substrate endotoxin assay for clinical use. J Clin Pathol (1983) 1.25
Isolation and characterization of microsatellite loci in a Phylloscopus warbler. Mol Ecol (1997) 1.24
A Report of Three Cases of Chordoma. Can Med Assoc J (1935) 1.22
Retrospect--personeal spastic flat foot (rigid valgus foot). J Bone Joint Surg Am (1965) 1.21
Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials. Part I: synthesis and evaluation. Biomaterials (1999) 1.20
Affinity chromatography. Methods Enzymol (1984) 1.18
Nephrotic syndrome during treatment with interferon. Br Med J (Clin Res Ed) (1985) 1.17
PEG-variant biomaterials as selectively adhesive protein templates: model surfaces for controlled cell adhesion and migration. Biomaterials (2000) 1.16
Method of removing abnormal protein rapidly from patients with malignant paraproteinaemias. Br Med J (1971) 1.14
Immunoglobulins in burned patients. Lancet (1969) 1.13
Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed) (1982) 1.13
Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm (2008) 1.13
Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut (1979) 1.12
Prevalence of bacteria in the vagina of normal young women. Br J Obstet Gynaecol (1981) 1.11
Tyrosine-derived polycarbonates: backbone-modified "pseudo"-poly (amino acids) designed for biomedical applications. Biopolymers (1992) 1.06
Design, synthesis, and preliminary characterization of tyrosine-containing polyarylates: new biomaterials for medical applications. J Biomater Sci Polym Ed (1994) 1.04
Comparative histological evaluation of new tyrosine-derived polymers and poly (L-lactic acid) as a function of polymer degradation. J Biomed Mater Res (1998) 1.03
Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol (1980) 1.03
Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part II: 3-yr study of polymeric devices. Biomaterials (2000) 1.02
Response persistence under ratio and interval reinforcement schedules. J Exp Anal Behav (1998) 1.01
Small changes in polymer chemistry have a large effect on the bone-implant interface: evaluation of a series of degradable tyrosine-derived polycarbonates in bone defects. Biomaterials (1999) 1.01
Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis. J Clin Pathol (1983) 1.00
Diabetes intervention in the information age. Med Inform (Lond) (1997) 1.00
The impact of initiatives in education, self-management training, and computer-assisted self-care on outcomes in diabetes disease management. Diabetes Technol Ther (2001) 0.99
[Experimental studies on the problem of bone conservation in plastic materials]. Dtsch Zahnarztl Z (1967) 0.98
Serum-alpha1-fetoprotein in patients with testicular tumours. Lancet (1976) 0.97
A waste-trap-sterilising method. Lancet (1970) 0.97
Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: study of model compounds. Biomaterials (2000) 0.96
Simplified procedure for immunodiffusion techniques on cellulose acetate. Nature (1968) 0.94
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma. Gut (1978) 0.94
Pseudomonas infection in hospital. Br Med J (1967) 0.94
Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours. Br J Cancer (1977) 0.94
Microphase separation in copolymers of hydrophilic PEG blocks and hydrophobic tyrosine-derived segments using simultaneous SAXS/WAXS/DSC. Polymer (Guildf) (2010) 0.93
Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol (1999) 0.93
Canine bone response to tyrosine-derived polycarbonates and poly(L-lactic acid). J Biomed Mater Res (1996) 0.92
Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance. J Virol (1996) 0.92
Hospital admissions for whooping cough in the Oxford Region, 1974-9. Br Med J (Clin Res Ed) (1981) 0.92
Benign paraproteinaemias. J Clin Pathol Suppl (Assoc Clin Pathol) (1975) 0.92
Carbon nanotube fibers are compatible with Mammalian cells and neurons. IEEE Trans Nanobioscience (2008) 0.92
A cellulose acetate immunofixation technique. J Immunol Methods (1978) 0.92
Self-incompatibility RNases from three plant families: homology or convergence? Am J Bot (1997) 0.91
Abnormal immune response in burns. Postgrad Med J (1972) 0.91
Endotoxaemia as a cause of fever in immunosuppressed patients. J Clin Pathol (1984) 0.91
A colorimetric method for monitoring activation of Sepharose by cyanogen bromide. Biochem Biophys Res Commun (1978) 0.91
C reactive protein rapid assay techniques for monitoring resolution of infection in immunosuppressed patients. J Clin Pathol (1984) 0.90
Results of the second international study on the W.H.O. alpha-foetoprotein standard. J Biol Stand (1978) 0.90
Pulmonary embolism associated with self-administration of mercury. Hum Toxicol (1986) 0.89
The use of concanavalin A to measure acute phase proteins by laser nephelometry. J Immunol Methods (1980) 0.89
Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients. J Clin Pathol (1979) 0.89
Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut (1976) 0.88
Letter: Standardisation of alpha-fetoprotein assays. Lancet (1976) 0.88
Trends in the development of bioresorbable polymers for medical applications. J Biomater Appl (1992) 0.87
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ). Acta Paediatr Scand (1976) 0.87
Procedures for the analysis of cyanogen bromide-activated Sepharose or Sephadex by quantitative determination of cyanate esters and imidocarbonates. Anal Biochem (1981) 0.87
A study of changes in red cell volume and haemoglobin concentration during phlebotomy induced iron deficiency and iron repletion using the Technicon H1. Clin Lab Haematol (1991) 0.87
Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes Cancer (2001) 0.87
Improved resolution of cellulose acetate membrane electrophoresis. Ann Clin Biochem (1987) 0.87
Autocrine hepatocyte growth factor provides a local mechanism for promoting axonal growth. J Neurosci (1998) 0.87
A highly sensitive colorimetric method for the determination of carbodiimides. Anal Biochem (1981) 0.86
The use of the technicon H1 in the diagnosis of hereditary spherocytosis. Clin Lab Haematol (1989) 0.86
Comparing two head injury treatments by linear logistic model. Acta Neurochir (Wien) (1982) 0.85
Characterization of the inflammatory response to biomaterials using a rodent air pouch model. J Biomed Mater Res (2000) 0.85
Letter: Medical graduates in clinical chemistry. Br Med J (1975) 0.85
Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers. Bioconjug Chem (1993) 0.84
The relationship of impulse control to parent hearing status, manual communication, and academic achievement in deaf children. Am Ann Deaf (1978) 0.84
Vitamin A and retinol-binding protein in patients with myelomatosis and cancer of epithelial origin. Eur J Cancer Clin Oncol (1982) 0.84
Obliterative Vascular Disease: Treatment by Sympathectomy. Can Med Assoc J (1941) 0.83
Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers. Psychoneuroendocrinology (1982) 0.83
Histopathology and medical laboratory scientific officers. Accreditation refused. BMJ (1994) 0.82
An epidemiological study of atopy in children. Clin Allergy (1988) 0.82
Tyrosine-derived nanospheres for enhanced topical skin penetration. Int J Pharm (2007) 0.82
Low-dose factor VIII in adults with haemophilic arthropathy. Lancet (1979) 0.81
Angiogenic competency of biodegradable hydrogels fabricated from polyethylene glycol-crosslinked tyrosine-derived polycarbonates. Eur Cell Mater (2008) 0.81
Identification and colorimetric determination of organic cyanates in nanomolar quantities. Anal Chem (1986) 0.81
Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res (1985) 0.81
A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. 1. Clinical aspects. Allergy (1989) 0.81
Study of nanoscale structures in hydrated biomaterials using small-angle neutron scattering. Acta Biomater (2011) 0.81
The study of water uptake in degradable polymers by thermally stimulated depolarization currents. Biomaterials (1998) 0.80